Table 1.
Baseline characteristics of IS and AMI populations
| Post-IS group | Post-AMI group | |||
|---|---|---|---|---|
| N | % | N | % | |
| Patients selected to the study | 500 | 100.0 | 550 | 100.0 |
| Patients followed in the study | 464 | 100.0 | 533 | 100.0 |
| Sex | ||||
| Women | 208* | 44.8 | 180* | 33.8 |
| Men* | 256* | 55.2 | 353* | 66.2 |
| Deaths from 2000 to 2011* | ||||
| Women | ||||
| 30–64 | 27* | 29.3 | 8* | 12.5 |
| >64 | 64* | 55.2 | 59 | 50.9 |
| >30 | 91* | 43.8 | 67 | 37.2 |
| Men | ||||
| 30–64* | 59* | 46.1 | 51* | 27.6 |
| >64 | 89* | 69.0 | 89 | 53.0 |
| >30 | 148* | 57.8 | 140 | 39.7 |
| All** | 239 | 51.5 | 207 | 38.8 |
| Age at event | ||||
| Mean ± SD | 63.3 ± 9.6 | 62.3 ± 9.6 | ||
| Median ± IR | 65 ± 15 | 65 ± 15 | ||
| Years of follow-up (median) | 8.5 | 8.0 | ||
| Age of death (mean ± SD) | 74.0 ± 7.6 | 72.0 ± 8.8 | ||
SD standard deviation, IR interquartile range
* p < 0.05 for men–women comparisons (Chi square test)
** p < 0.05 for IS–AMI comparison (Chi square test)